Multiple drugsOff label use, pulmonary aspergillosis and COVID-19 pneumonitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1879卷 / 1期

关键词：

D O I：

10.1007/s40278-021-04751-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：267 / 267

相关论文

共 50 条

[1] Multiple drugsOff-label use and failure to respond in COVID-19: case report
Reactions Weekly, 2022, 1909 (1) : 408 - 408
[2] Multiple drugsOff-label use, invasive pulmonary aspergillosis and acquired drug resistance: case report
Reactions Weekly, 2021, 1876 (1) : 231 - 231
[3] Multiple drugsOff label use and lack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 335 - 335
[4] Multiple drugsOff label use and lack of efficacy: case report
Reactions Weekly, 2022, 1935 (1) : 317 - 317
[5] Multiple drugsOff label use and lack of efficacy: case report
Reactions Weekly, 2021, 1878 (1) : 362 - 362
[6] Multiple drugsOff label use and lack of efficacy: case report
Reactions Weekly, 2022, 1922 (1) : 431 - 431
[7] Multiple drugsOff label use and lack of efficacy: case report
Reactions Weekly, 2023, 1978 (1) : 271 - 271
[8] Multiple drugsOff label use and lack of efficacy: case report
Reactions Weekly, 2020, 1823 (1) : 250 - 250
[9] Multiple drugsOff label use and lack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 948 - 948
[10] Multiple drugsOff label use and QTc prolongation: case report
Reactions Weekly, 2021, 1848 (1) : 284 - 284

← 1 2 3 4 5 →